OBJECTIVE: Our objective was to study age at menopause and the factors associated with it in a large population-based group of Finnish women with childhood-onset type 1 diabetes. METHODS: We contacted a sample of 978 women with type 1 diabetes and mailed them a questionnaire on their gynecological and reproductive histories, diabetes and its management, other diseases, and lifestyle factors. The questionnaire survey was repeated 3 years later among those 641 who responded in the first round and were eligible to take part. Both cross-sectional and retrospective epidemiological cohort study designs were applied to study factors associated with the occurrence of menopause. RESULTS: The median age at cessation of menstruation observed in women with type 1 diabetes was 52.5 years, not lower than that of the general Finnish population (median, 51 y). Women with end-stage renal disease (prevalence ratio, 2.22; 95% CI, 1.22-4.02; P = 0.009) or proliferative retinopathy (prevalence ratio, 1.89; 95% CI, 1.11-3.21; P = 0.02) were more likely than others to have entered menopause by the time of the study. Both associations remained statistically significant after age adjustment. CONCLUSIONS: Age at menopause in women with type 1 diabetes is not lower than that in the general population in Finland. The only statistically significant factors independently associated with earlier menopause in our study were microvascular complications, that is, end-stage renal disease and proliferative retinopathy.
OBJECTIVE: Our objective was to study age at menopause and the factors associated with it in a large population-based group of Finnish women with childhood-onset type 1 diabetes. METHODS: We contacted a sample of 978 women with type 1 diabetes and mailed them a questionnaire on their gynecological and reproductive histories, diabetes and its management, other diseases, and lifestyle factors. The questionnaire survey was repeated 3 years later among those 641 who responded in the first round and were eligible to take part. Both cross-sectional and retrospective epidemiological cohort study designs were applied to study factors associated with the occurrence of menopause. RESULTS: The median age at cessation of menstruation observed in women with type 1 diabetes was 52.5 years, not lower than that of the general Finnish population (median, 51 y). Women with end-stage renal disease (prevalence ratio, 2.22; 95% CI, 1.22-4.02; P = 0.009) or proliferative retinopathy (prevalence ratio, 1.89; 95% CI, 1.11-3.21; P = 0.02) were more likely than others to have entered menopause by the time of the study. Both associations remained statistically significant after age adjustment. CONCLUSIONS: Age at menopause in women with type 1 diabetes is not lower than that in the general population in Finland. The only statistically significant factors independently associated with earlier menopause in our study were microvascular complications, that is, end-stage renal disease and proliferative retinopathy.
Authors: J S Brand; N C Onland-Moret; M J C Eijkemans; A Tjønneland; N Roswall; K Overvad; G Fagherazzi; F Clavel-Chapelon; L Dossus; A Lukanova; V Grote; M M Bergmann; H Boeing; A Trichopoulou; M Tzivoglou; D Trichopoulos; S Grioni; A Mattiello; G Masala; R Tumino; P Vineis; H B Bueno-de-Mesquita; E Weiderpass; M L Redondo; M J Sánchez; J M Huerta Castaño; L Arriola; E Ardanaz; E J Duell; O Rolandsson; P W Franks; S Butt; P Nilsson; K T Khaw; N Wareham; R Travis; I Romieu; M J Gunter; E Riboli; Y T van der Schouw Journal: Hum Reprod Date: 2015-03-15 Impact factor: 6.918
Authors: Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Trevor J Orchard; Tina Costacou Journal: Menopause Date: 2021-04-05 Impact factor: 2.953
Authors: Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Trevor J Orchard; Tina Costacou Journal: J Diabetes Complications Date: 2021-01-02 Impact factor: 2.852
Authors: Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Karen Matthews; Trevor J Orchard; Tina Costacou Journal: Menopause Date: 2021-03-01 Impact factor: 3.310
Authors: Catherine Kim; Patricia A Cleary; Catherine C Cowie; Barbara H Braffett; Rodney L Dunn; Mary E Larkin; Patricia M Gatcomb; Hunter B Wessells; David M Nathan; Aruna V Sarma Journal: Diabetes Care Date: 2013-10-29 Impact factor: 19.112